ARTICLES BY JEREMY SCHAFER
-
Designing Clinical Trials With The Payer In Mind11/6/2018
Imagine your company just received FDA approval of a new pharmaceutical, the result of years of clinical research and difficult regulatory scrutiny. The product is being manufactured and is shipping to distributors and wholesalers. Providers and patient advocacy groups seem excited for the launch, and sales goals are considered aggressive. However, one key variable remains: coverage.
This website uses cookies to ensure you get the best experience on our website. Learn more